Conservation of expression and alternative splicing in the prosaposin gene

Molecular Brain Research

Volumn 129, Issue 1-2, 2004, Pages 8-19

  Cohen, Tsadok ^a   Ravid, Liat ^a   Altman, Netta ^a   Madar Shapiro, Liora ^a   Fein, Amos ^a   Weil, Miguel ^a   Horowitz, Mia ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alternative splicing; Prosaposin; Saposins

Indexed keywords

MESSENGER RNA; PROSAPOSIN; RNA;

ALTERNATIVE RNA SPLICING; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN DEVELOPMENT; CHICKEN; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE STRUCTURE; GENETIC CONSERVATION; GENETIC PROCEDURES; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKELETAL MUSCLE; SMOOTH MUSCLE; VISCERA; ZEBRA FISH;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CHICK EMBRYO; EVOLUTION, MOLECULAR; EXONS; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SAPOSINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; TISSUE DISTRIBUTION;

DANIO RERIO;

EID: 4644296741     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.06.027     Document Type: Article

References (67)

1. V.E. Ahn, K.F. Faull, J.P. Whitelegge, A.L. Fluharty, and G.G. Prive Crystal structure of saposin B reveals a dimeric shell for lipid binding Proc. Natl. Acad. Sci. U. S. A. 100 2003 38 43
2. R.P. Amann, G.E. Seidel, and Z.A. Brink Exposure of thawed frozen bull sperm to a synthetic peptide before artificial insemination increases fertility J. Androl. 20 1999 42 46
3. N. Azuma, H.C. Seo, O. Lie, Q. Fu, R.M. Gould, M. Hiraiwa, D.W. Burt, I.R. Paton, D.R. Morrice, J.S. O'Brien, and Y. Kishimoto Cloning, expression and map assignment of chicken prosaposin Biochem. J. 330 1998 321 327
4. N.A. Calcutt, W.M. Campana, N.L. Eskeland, L. Mohiuddin, K.C. Dines, A.P. Mizisin, and J.S. O'Brien Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats J. Neuropathol. Exp. Neurol. 58 1999 628 636
5. W.M. Campana, M. Hiraiwa, K.C. Addison, and J.S. O'Brien Induction of MAPK phosphorylation by prosaposin and prosaptide in PC12 cells Biochem. Biophys. Res. Commun. 229 1996 706 712
6. W.M. Campana, M. Hiraiwa, and J.S. O'Brien Prosaptide activates the MAPK pathway by a G-protein-dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells FASEB J. 12 1998 307 314
7. W.M. Campana, S.J. Darin, and J.S. O'Brien Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells J. Neurosci. Res. 57 1999 332 341
8. C.Y. Chen, and A.B. Shyu AU-rich elements: characterization and importance in mRNA degradation Trends Biochem. Sci. 20 1995 465 470
9. R. Dal Toso, B. Sommer, M. Ewert, A. Herb, D.B. Pritchett, A. Bach, B.D. Shivers, and P.H. Seeburg The dopamine D2 receptor: two molecular forms generated by alternative splicing EMBO J. 8 1989 4025 4034
10. C.J. Decker, and R. Parker Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts Curr. Opin. Cell Biol. 7 1995 386 392
11. N. Fujita, K. Suzuki, M.T. Vanier, B. Popko, N. Maeda, A. Klein, M. Henseler, K. Sandhoff, H. Nakayasu, and K. Suzuki Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids Hum. Mol. Genet. 5 1996 711 725
12. W. Fürst, W. Machleidt, and K. Sandhoff The precursor of sulfatide activator protein is processed to three different proteins Biol. Chem. Hoppe-Seyler 369 1988 317 328
13. B. Giros, P. Sokoloff, M.P. Martres, J.F. Riou, L.J. Emorine, and J.C. Schwartz Alternative splicing directs the expression of two D2 dopamine receptor isoforms Nature 342 1989 923 926
14. P.J. Grabowski, and D.L. Black Alternative RNA splicing in the nervous system Prog. Neurobiol. 65 2001 289 308
15. D.K. Grandy, M.A. Marchionni, H. Makam, R.E. Stofko, M. Alfano, L. Frothingham, J.B. Fischer, K.J. Burke-Howie, J.R. Bunzow, and A.C. Server Cloning of the cDNA and gene for a human D2 dopamine receptor Proc. Natl. Acad. Sci. U. S. A. 86 1989 9762 9766
16. R.H. Hammerstedt, P.G. Cramer, G.F. Barbato, R.P. Amann, J.S. O'Brien, and M.D. Griswold A fragment of prosaposin (SGP-1) from rooster sperm promotes sperm-egg binding and improves fertility in chickens J. Androl. 22 2001 361 375
17. K. Harzer, B.C. Paton, A. Poulos, B. Kustermann-Kuhn, W. Roggendorf, T. Grisar, and M. Popp Sphingolipid activator protein deficiency in a 16-weekold atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses Eur. J. Pediatr. 149 1989 31 39
18. M. Henseler, A. Klein, G.J. Glombitza, K. Suziki, and K. Sandhoff Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system J. Biol. Chem. 271 1996 8416 8423
19. M.W. Hentze, and L.C. Kuhn Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress Proc. Natl. Acad. Sci. U. S. A. 93 1996 8175 8182
20. T. Hineno, A. Sano, K. Kondoh, S. Ueno, Y. Kakimoto, and K. Yoshida Secretion of sphingolipid hydrolase activator precursor, prosaposin Biochem. Biophys. Res. Commun. 176 1991 668 674
21. M. Hiraiwa, B.M. Martin, Y. Kishimoto, G.E. Conner, S. Tsuji, and J.S. O'Brien Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside Arch. Biochem. Biophys. 341 1997 17 24
22. M. Hiraiwa, E.M. Taylor, W.M. Campana, S.J. Darin, and J.S. O'Brien Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides Proc. Natl. Acad. Sci. U. S. A. 94 1997 4778 4781
23. M. Hiraiwa, W.M. Campana, A.P. Mizisin, L. Mohiuddin, and J.S. O'Brien Prosaposin: a myelinotrophic protein that promotes expression of myelin constituents and is secreted after nerve injury Glia 26 1999 353 360
24. M. Hiraiwa, J. Liu, A.G. Lu, C.Y. Wang, R. Misasi, T. Yamauchi, I. Hozumi, T. Inuzuka, and J.S. O'Brien Regulation of gene expression in response to brain injury: enhanced expression and alternative splicing of rat prosaposin (SGP-1) mRNA in injured brain J. Neurotrauma 20 2003 755 765
25. H. Holtschmidt, K. Sandhoff, H.Y. Kwon, K. Harzer, T. Nakano, and K. Suzuki Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease J. Biol. Chem. 266 1991 7556 7560
26. I. Hozumi, M. Hiraiwa, T. Inuzuka, Y. Yoneoka, K. Akiyama, R. Tanaka, K. Kikugawa, R. Nakano, S. Tsuji, and J.S. O'Brien Administration of prosaposin ameliorates spatial learning disturbance and reduces cavity formation following stab wounds in rat brain [in process citation] Neurosci. Lett. 267 1999 73 76
27. H. Hulková, M. Cervenková, J. Ledvinová, M. Tochácková, M. Hrebícek, H. Poupetová, A. Befekadu, L. Berná, B.C. Paton, K. Harzer, A. BöÄr, F. Šmíd, and M. Elleder A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation Hum. Mol. Genet. 10 2001 927 940
28. K. Igase, J. Tanaka, Y. Kumon, B. Zhang, Y. Sadamoto, N. Maeda, S. Sakaki, and M. Sakanaka An 18-mer peptide fragment of prosaposin ameliorates place navigation disability, cortical infarction, and retrograde thalamic degeneration in rats with focal cerebral ischemia J. Cereb. Blood Flow Metab. 19 1999 298 306
29. Y. Kishimoto, M. Hiraiwa, and J.S. O'Brien Saposins: structure, function, distribution, and molecular genetics J. Lipid Res. 33 1992 1255 1267
30. A. Klein, M. Henseler, C. Klein, K. Suzuki, K. Harzer, and K. Sandhoff Sphingolipid activator protein D (Sap-D) stimulates the lysosomal degradation of ceramide in-vivo Biochem. Biophys. Res. Commun. 200 1994 1440 1448
31. K. Kondoh, T. Hineno, A. Sano, and Y. Kakimoto Isolation and characterization of prosaposin from human milk Biochem. Biophys. Res. Commun. 181 1991 286 292
32. K.A. Kretz, G.S. Carson, S. Morimoto, Y. Kishimoto, A.L. Fluharty, and J.S. O'Brien Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect Proc. Natl. Acad. Sci. U. S. A. 87 1990 2541 2544
33. S. Lamontagne, and M. Potier Modulation of human saposin B sphingolipidbinding specificity by alternative splicing. A study with saposin B-derived synthetic peptides J. Biol. Chem. 269 1994 20528 20532
34. P.A. Lapchak, D.M. Araujo, D.A. Shackelford, and J.A. Zivin Prosaptide exacerbates ischemia-induced behavioral deficits in vivo; an effect that does not involve mitogen-activated protein kinase activation Neuroscience 101 2000 811 814
35. S. Lefrancois, J. Zeng, A.J. Hassan, M. Canuel, and C.R. Morales The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin EMBO J. 22 2003 6430 6437
36. L. Madar-Shapiro, M. Pasmanik-Chor, A.M. Vaccaro, T. Dinur, A. Dagan, S. Gatt, and M. Horowitz Importance of splicing for prosaposin sorting Biochem. J. 337 1999 433 443
37. S.F. Magargee, P.G. Cramer, and R.H. Hammerstedt Increased in vitro binding and fertilizing ability of mouse sperm exposed to a synthetic peptide Mol. Reprod. Dev. 57 2000 406 411
38. J. Matsuda, M.T. Vanier, Y. Saito, J. Tohyama, and K. Suzuki A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse Hum. Mol. Genet. 10 2001 1191 1199
39. L. Mintz, E. Galperin, M. Pasmanik-Chor, S. Tulzinsky, Y. Bromberg, C.A. Kozak, A. Joyner, A. Fein, and M. Horowitz EHD1â€"an EH-domain-containing protein with a specific expression pattern Genomics 59 1999 66 76
40. R. Misasi, M. Sorice, G.S. Carson, T. Griggi, L. Lenti, G.M. Pontieri, and J.S. O'Brien Prosaposin and prosaptide, a peptide from prosaposin, induce an increase in ganglioside content on NS20Y neuroblastoma cells Glycoconj. J. 13 1996 195 202
41. R. Misasi, M. Sorice, L.L. Di Marzio, W.M. Campana, S. Molinari, M.G. Cifone, A. Pavan, G.M. Pontieri, and J.S. O'Brien Prosaposin treatment induces PC12 entry in the S phase of the cell cycle and prevents apoptosis: activation of ERKs and sphingosine kinase FASEB J. 15 2001 467 474
42. C.R. Morales, and H. Badran Prosaposin ablation inactivates the MAPK and Akt signaling pathways and interferes with the development of the prostate gland Asian J. Androl. 5 2003 57 63
43. C.R. Morales, Q. Zhao, M. El-Alfy, and K. Suzuki Targeted disruption of the mouse prosaposin gene affects the development of the prostate gland and other male reproductive organs J. Androl. 21 2000 765 775
44. C.R. Morales, Q. Zhao, S. Lefrancois, and D. Ham Role of prosaposin in the male reproductive system: effect of prosaposin inactivation on the testis, epididymis, prostate, and seminal vesicles Arch. Androl. 44 2000 173 186
45. T. Nakano, K. Sandhoff, J. Stüper, H. Christomanou, and K. Suzuki Structure of full-length cDNA coding for sulfatide activator, a Co-beta-glucosidase and two other homologous proteins: two alternate forms of the sulfatide activator J. Biochem. (Tokyo) 105 1989 152 154
46. J.S. O'Brien, K.A. Kretz, N. Dewji, D.A. Wenger, F. Esch, and A.L. Fluharty Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus Science 241 1988 1098 1101
47. J.S. O'Brien, G.S. Carson, H.C. Seo, M. Hiraiwa, and Y. Kishimoto Identification of prosaposin as a neurotrophic factor Proc. Natl. Acad. Sci. U. S. A. 91 1994 9593 9596
48. J.S. O'Brien, G.S. Carson, H.C. Seo, M. Hiraiwa, S. Weiler, J.M. Tomich, J.A. Barranger, M. Kahn, N. Azuma, and Y. Kishimoto Identification of the neurotrophic factor sequence of prosaposin FASEB J. 9 1995 681 685
49. X. Qi, W. Qin, Y. Sun, K. Kondoh, and G.A. Grabowski Functional organization of saposin C. Definition of the neurotrophic and acid betaglucosidase activation regions J. Biol. Chem. 271 1996 6874 6880
50. X. Qi, K. Kondoh, D. Krusling, G.J. Kelso, T. Leonova, and G.A. Grabowski Conformational and amino acid residue requirements for the saposin C neuritogenic effect Biochemistry 38 1999 6284 6291
51. M.A. Rafi, X.L. Zhang, G. DeGala, and D.A. Wenger Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy Biochem. Biophys. Res. Commun. 166 1990 1017 1023
52. M.A. Rafi, G. de Gala, X.L. Zhang, and D.A. Wenger Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency Somat. Cell Mol. Genet. 19 1993 1 7
53. S. Regis, M. Filocamo, F. Corsolini, F. Caroli, J.L. Keulemans, O.P. van Diggelen, and R. Gatti An Asn>Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity Eur. J. Hum. Genet. 7 1999 125 130
54. M. Rende, E. Brizi, R. Donato, C. Provenzano, R. Bruno, A.P. Mizisin, R.S. Garrett, N.A. Calcutt, W.M. Campana, and J.S. O'Brien Prosaposin is immunolocalized to muscle and prosaptides promote myoblast fusion and attenuate loss of muscle mass after nerve injury Muscle Nerve 24 2001 799 808
55. E.G. Rorman, and G.A. Grabowski Molecular cloning of a human co-betaglucosidase cDNA: evidence that four sphingolipid hydrolase activator proteins are encoded by single genes in humans and rats Genomics 5 1989 486 492
56. K. Sandhoff, and T. Kolter Biosynthesis and degradation of mammalian glycosphingolipids Philos. Trans. R. Soc. Lond., B Biol. Sci. 358 2003 847 861
57. A. Sano, T. Hineno, T. Mizuno, K. Kondoh, S. Ueno, Y. Kakimoto, and K. Inui Sphingolipid hydrolase activator proteins and their precursors Biochem. Biophys. Res. Commun. 165 1989 1191 1197
58. D. Schnabel, M. Schroder, and K. Sandhoff Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease FEBS Lett. 284 1991 57 59
59. H. Sprecher-Levy, A. Orr-Urtreger, P. Lonai, and M. Horowitz Murine prosaposin: expression in the reproductive system of a gene implicated in human genetic diseases Cell. Mol. Biol. (Noisy-le-Grand) 39 1993 287 299
60. S.R. Sylvester, C. Morales, R. Oko, and M.D. Griswold Sulfated glycoprotein-1 (saposin precursor) in the reproductive tract of the male rat Biol. Reprod. 41 1989 941 948
61. K. Tsuboi, M. Hiraiwa, and J.S. O'Brien Prosaposin prevents programmed cell death of rat cerebellar granule neurons in culture Dev. Brain Res. 110 1998 249 255
62. M. Tsuda, T. Sakiyama, H. Endo, and T. Kitagawa The primary structure of mouse saposin Biochem. Biophys. Res. Commun. 184 1992 1266 1272
63. D. Wrobe, M. Henseler, S. Huettler, S.I. Pascual, A. Chabas, and K. Sandhoff A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD) J. Inherit. Metab. Dis. 23 2000 63 76
64. J. Xie, and D.L. Black A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels Nature 410 2001 936 939
65. G.X. Xie, K. Jones, S.J. Peroutka, and P.P. Palmer Detection of mRNAs and alternatively spliced transcripts of dopamine receptors in rat peripheral sensory and sympathetic ganglia Brain Res. 785 1998 129 135
66. X.L. Zhang, M.A. Rafi, G. DeGala, and D.A. Wenger The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid a ctivator protein (SAP-1)-deficient metachromatic leukodystrophy Hum. Genet. 87 1991 211 215
67. Q. Zhao, N. Hay, and C.R. Morales Structural analysis of the mouse prosaposin (SGP-1) gene reveals the presence of an exon that is alternatively spliced in transcribed mRNAs Mol. Reprod. Dev. 48 1997 1 8